Therapie der Manie

Die Manie ist ein facettenreiches psychopathologisches Phänomen. Ziel jeder Behandlung sind das Aufrechterhalten bzw. Wiedererlangen eines hohen psychosozialen Funktionsniveaus und das Abwenden von Schäden, die durch krankheitsbedingte Verhaltensstörungen entstehen können. Moderne Therapiekonzepte sind trialogisch ausgerichtet und vereinen psychotherapeutische, sozialmedizinische sowie chronotherapeutische Ansätze mit einer gezielten Pharmakotherapie.

Schlüsselwörter

Manie - Chronotherapie - Therapieresistenz - bipolare Störung - Psychotherapie

• Literatur

• 1 WHO. International Classification of Diseases, Eleventh Revision (ICD-11). Accessed March 17, 2024 at: https://www.who.int/standards/classifications/classification-of-diseases
• 2 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition. Washington, DC: American Psychiatric Publishing; 2013.
• 3 Bauer M, Pfennig A, Schäfer M. et al. S3-Leitlinie zur Diagnostik und Therapie Bipolarer Störungen. Berlin: Springer; 2020.
• 4 Nolen WA, Licht RW, Young AH. et al. What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD/IGSLI Task Force on treatment with lithium. Bipolar Disord 2019; 21: 394-409
• 5 Amsterdam JD, Xu C. Multi-trial, aggregated, individual participant data mega-analysis of short-term antidepressant versus mood stabilizer monotherapy of bipolar type II major depressive episode. Bipolar Disord 2023;
• 6 McGirr A, Vöhringer PA, Ghaemi SN. et al. Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials. Lancet Psychiatry 2016; 3: 1138-1146
• 7 Kishi T, Ikuta T, Matsuda Y. et al. Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials. Mol Psychiatry 2022; 27: 1136-1144
• 8 DGPPN. S2k-Leitlinie Notfallpsychiatrie. Berlin: Springer; 2020
• 9 Smith KA, Cipriani A. Lithium and suicide in mood disorders: Updated meta-review of the scientific literature. Bipolar Disord 2017; 19: 575-586
• 10 Bauer M, Berghöfer A, Brakemeier EL. et al. Therapieresistenz bei bipolarer Depression und Manie. et al. In: Krug CK, Ludwig VM, Bauer M. Therapieresistenz bei Depressionen und bipolaren Störungen. Berlin: Springer; 2022: 263-282
• 11 Meyer TD, Hautzinger M. Bipolare Störungen. Kognitiv-verhaltenstherapeutisches Behandlungsmanual; mit Online-Materialien. Weinheim: Beltz; 2013
• 12 Miklowitz DJ. Bipolar disorder. A family-focused treatment approach. New York: Guilford; 2010.
• 13 Frank E. Treating bipolar disorder. A clinician’s guide to interpersonal and social rhythm therapy. Guides to individualized evidence based treatment. New York: Guilford; 2007
• 14 Zwick JC, Hautzinger M. Kognitive Verhaltenstherapie bei affektiven Störungen. PSYCH up2date 2020; 14: 399-414
• 15 Geoffroy PA, Bellivier F, Scott J. et al. Seasonality and bipolar disorder: a systematic review, from admission rates to seasonality of symptoms. J Affect Disord 2014; 168: 210-223
• 16 Gottlieb JF, Benedetti F, Geoffroy PA. et al. The chronotherapeutic treatment of bipolar disorders: A systematic review and practice recommendations from the ISBD task force on chronotherapy and chronobiology. Bipolar Disord 2019; 21: 741-773
• 17 Hirakawa H, Terao T, Muronaga M. et al. Adjunctive bright light therapy for treating bipolar depression: A systematic review and meta-analysis of randomized controlled trials. Brain Behav 2020; 10: e01876
• 18 Barbini B, Benedetti F, Colombo C. et al. Dark therapy for mania: a pilot study. Bipolar Disord 2005; 7: 98-101
• 19 Henriksen TE, Skrede S, Fasmer OB. et al. Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial. Bipolar Disord 2016; 18: 221-232